Report ID |
136050 |
Drug Identification Number |
02237820 |
Brand name |
AMERGE |
Common or Proper name |
naratriptan hydrochloride tablets |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
NARATRIPTAN |
Strength(s) |
1MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL
ORAL |
Packaging size |
2's |
ATC code |
N02CC |
ATC description |
ANTIMIGRAINE PREPARATIONS |
Reason for shortage |
Disruption of the manufacture of the drug. |
Anticipated start date |
|
Actual start date |
2021-04-08 |
Estimated end date |
2021-04-26 |
Actual end date |
2021-04-16 |
Shortage status |
Resolved |
Updated date |
2021-04-17 |
Company comments |
|
Health Canada comments |
|
Company contact information |
1-800-387-7374 |